Science
Column: Paper boosting stem cell firm’s treatments is retracted – Yahoo Finance
A paper co-authored by an executive of a stem cell firm already under FDA fire has been retracted.
The markets lately are a mix of gains and volatility, and its tough, sometimes, for investors to make sense of it. In times like these, it makes sense to turn to the experts. Cathie Wood is one such expert, an investor whose stock choices have consistently outperformed the overall markets. A protégé of famed economist Arthur Laffer, market guru Wood has built her reputation on her clear view of the markets. Her firm is Ark Invest, whose Innovation ETF has over $52 billion in assets under management,…
-
General12 hours agoCoroner to examine treatment of woman who died three days after surgery performed by former Queensland premier’s partner
-
General14 hours agoAlbanese beats drum on economy as trade clouds gather
-
Noosa News14 hours agoSurgeon partner of former premier to testify over his patient’s death
-
Business11 hours agoWhy Antipa, Cettire, Magnetic Resources, and Steadfast shares are pushing higher